Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-31

FDA Approved: QUTENZA — Supplemental Application (Averitas Pharma Inc)

View source ↗

Summary

The FDA approved a supplemental application for QUTENZA (capsaicin patch) from Averitas Pharma Inc. The approval covers changes described in the supplemental su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUTENZA (Capsaicin)

Snippet

SUPPL AP for QUTENZA (CAPSAICIN)